Jan Pukropski

Dr. Jan Pukropski

University Hospital Bonn, Bonn, North Rhine-Westphalia, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
RWRandi Von Wrede
Randi Von Wrede
TBTimo Bröhl
Timo Bröhl
TRThorsten Rings
Thorsten Rings
JPJan Pukropski
Jan Pukropski
CHChristoph Helmstaedter
Christoph Helmstaedter
KLKlaus Lehnertz
Klaus Lehnertz
Transcutaneous auricular vagus nerve stimulation (taVNS) is a novel non-invasive treatment option for different diseases and symptoms, such as epilepsy or depression. Its mechanism of action, however, is still not fully understood. We investigated short-term taVNS-induced changes of local and global properties of EEG-derived, evolving functional brain networks from eighteen subjects who underwent two 1 h stimulation phases (morning and afternoon) during continuous EEG-recording. In the majority of subjects, taVNS induced measurable modifications of network properties. Network alterations induced by stimulation in the afternoon were clearly more pronounced than those induced by stimulation in the morning. Alterations mostly affected the networks’ topology and stability properties. On the local network scale, no clear-cut spatial stimulation-related patterns could be discerned. Our findings indicate that the possible impact of diurnal influences on taVNS-induced network modifications would need to be considered for future research and clinical studies of this non-pharmaceutical intervention approach.

1 April 2025 in Epilepsia Open
Verified
Journal Article
Open access
LWLennart Walger
Lennart Walger
MSMatthias H Schmitz
Matthias H Schmitz
TBTobias Bauer
Tobias Bauer
DKDavid Kügler
David Kügler
FSFabiane Schuch
Fabiane Schuch
TRTheodor Rüber
Theodor Rüber
Objective: This study aims to report human performance in the detection of Focal Cortical Dysplasias (FCDs) using an openly available dataset. Additionally, it defines a subset of this data as a “difficult” test set to establish a public baseline benchmark against which new methods for automated FCD detection can be evaluated.Methods: The performance of 28 human readers with varying levels of expertise in detecting FCDs was originally analyzed using 146 subjects (not all of which are openly available), we analyzed the openly available subset of 85 cases. Performance was measured based on the overlap between predicted regions of interest (ROIs) and ground‐truth lesion masks, using the Dice‐Soerensen coefficient (DSC). The benchmark test set was chosen to consist of 15 subjects most predictive for human performance and 13 subjects identified by at most 3 of the 28 readers.Results: Expert readers achieved an average detection rate of 68%, compared to 45% for non‐experts and 27% for laypersons. Neuroradiologists detected the highest percentage of lesions (64%), while psychiatrists detected the least (34%). Neurosurgeons had the highest ROI sensitivity (0.70), and psychiatrists had the highest ROI precision (0.78). The benchmark test set revealed an expert detection rate of 49%.Significance: Reporting human performance in FCD detection provides a critical baseline for assessing the effectiveness of automated detection methods in a clinically relevant context. The defined benchmark test set serves as a useful indicator for evaluating advancements in computer‐aided FCD detection approaches.Plain Language Summary: Focal cortical dysplasias (FCDs) are malformations of cortical development and one of the most common causes of drug‐resistant focal epilepsy. Once found, FCDs can be neurosurgically resected, which leads to seizure freedom in many cases. However, FCDs are difficult to detect in the visual assessment of magnetic resonance imaging. A myriad of algorithms for automated FCD detection have been developed, but their true clinical value remains unclear since there is no benchmark dataset for evaluation and comparison to human performance. Here, we use human FCD detection performance to define a benchmark dataset with which new methods for automated detection can be evaluated.

17 February 2025 in Epilepsia
Verified
Journal Article
Open access
TBTobias Bauer
Tobias Bauer
HSHemmen Sabir
Hemmen Sabir
TBTobias Baumgartner
Tobias Baumgartner
ARAttila Rácz
Attila Rácz
JPJan Pukropski
Jan Pukropski
TRTheodor Rüber
Theodor Rüber
The detection of transient peri‐ictal magnetic resonance imaging (MRI) abnormalities has been variable after epileptic seizures. The most common reason for this variability is that abnormalities may disappear if the interval between seizure and scan acquisition is prolonged using conventional high‐field systems. Here, we deployed a portable ultra‐low‐field MRI system in the presurgical evaluation at the bedside of individuals with epilepsy. We hypothesized that this novel technology enables rapid postictal scans and reliably shows focal peri‐ictal MRI abnormalities in the seizure onset zone. A .064‐T Swoop Portable MR Imaging System was used. Postictally, an axial diffusion‐weighted sequence was acquired. The interictal MRI consisted of the diffusion‐weighted and three‐dimensional T1‐weighted sequences. Postictal–interictal difference maps of diffusion‐weighted volumes were calculated. Three individuals were included. Two individuals with focal aware seizures scanned 29 s and 19 min after the seizure, respectively, showed focal restrictions in diffusivity in the seizure onset zone, and a third individual scanned 5 h 45 min after a focal to bilateral tonic–clonic seizure showed global restrictions of diffusivity. Portable ultra‐low‐field MRI opens a new line of inquiry with the aim to establish postictal seizure imaging as part of the presurgical evaluation of people with epilepsy.

10 October 2025 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Open access
FJFilippo Maria Piana Jacquot
Filippo Maria Piana Jacquot
ATAmadeo Touet
Amadeo Touet
AMAlessandra Menon
Alessandra Menon
TBTobias Baumgartner
Tobias Baumgartner
JPJan Pukropski
Jan Pukropski
DCDavide Cucchi
Davide Cucchi
Patients with epilepsy often sustain uncommon shoulder injuries, including bilateral lesions and posterior dislocations. Increased glenoid retroversion is associated with posterior instability, although it remains unclear whether this is a cause or an adaptation. During tonic-clonic seizures, the humeral head is driven cranially and posteriorly against the glenoid by muscle contractions, potentially leading to acute dislocation or plastic deformation, which can be particularly relevant during skeletal development, even without instability episodes. This cross-sectional study aimed to evaluate whether the cumulative frequency of tonic-clonic seizures affects glenoid anatomy in patients with epilepsy who have not experienced shoulder instability. Patients with epilepsy referred to a tertiary epilepsy center were enrolled sequentially. The duration of epilepsy and the frequency of tonic-clonic seizures were recorded and the glenoid version, the glenoid vault angle and the scapulohumeral subluxation index were measured on axial magnetic resonance imaging scans. The cumulative Burden of Recurrent Seizures over Time (BuRST) was calculated multiplying the duration of epilepsy by the number of yearly tonic-clonic seizures to compare patients with no BuRST, with those with a low BuRST (<40) and with a high BuRST (≥40). Statistical tests, including one-way analysis of variance with post hoc Tukey's test for multiple comparisons, were used to assess variable differences, correlations, and measurement reliability. Data were collected for 91 epileptic patients, 34 of which with a low and 28 with a high BuRST. A significant difference between the 3 BuRST groups emerged for all investigated parameters, with higher BuRST correlated with more pronounced changes (glenoid version angle: -1.93 ± 4.02°; -3.80 ± 4.34°; -6.67 ± 4.73°; glenoid vault angle: -12.78 ± 3.81°; -16.58 ± 4.02°; -20.66 ± 4.35°; subluxation index: 51.2% ± 4.7%; 54.6% ± 5.2%; 55.9% ± 5.1%). Intra- and interrater reliability was good to excellent for angular measurements and moderate to good for subluxation measurements. Patients with epilepsy who experience frequent tonic-clonic seizures, but have not yet had a shoulder instability episode, show increased glenoid retroversion, a more retroverted vault, and a higher scapulohumeral subluxation index compared to those with none or rare tonic-clonic seizures. These findings may suggest a possible link between recurrent tonic-clonic seizures and plastic deformation of the glenoid during growth, potentially influenced by repeated, powerful posteriorly directed muscular contractions. Although causality cannot be established, these results may pave the way for prospective studies aimed at better understanding the increased incidence of posterior shoulder instability observed in patients with epilepsy and recurrent tonic-clonic seizures.

19 October 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
ALAnnalena Lange
Annalena Lange
TBTobias Bauer
Tobias Bauer
NHNina Rebecca Held
Nina Rebecca Held
TRTheda von der Recke
Theda von der Recke
LKLennart Kersting
Lennart Kersting
TRTheodor Rüber
Theodor Rüber
Deep learning and ultra-high-field 7 Tesla (7T) MRI offer potential to improve detection of focal cortical dysplasia (FCD). However, existing models are predominantly trained on 3T MRI, and sufficiently large, annotated 7T datasets are not yet available. We evaluated a 3T-trained FCD detection model on paired 3T and 7T MRI acquired prospectively during presurgical assessment in 2023-2024. The cohort included 115 patients with epilepsy and 10 healthy controls, all undergoing T1-weighted and fluid-attenuated inversion recovery imaging at both field strengths. A publicly available 3D U-Net generated candidate lesions (>0.1 mL), which were compared with manual annotations and independently reviewed by two neuroradiologists and two epileptologists. Based on clinical MRI reports, patients were classified as MRI-suspected FCD (n=11), MRI-negative (n=64), or other lesion (n=40). In MRI-suspected FCD, sensitivity was 45% (5/11) at 7T versus 55% (6/11) at 3T. Among MRI-negative patients, diagnostic yield was 2% (1/64) at 7T versus 11% (7/64) at 3T. Across MRI-negative and other-lesion groups, the model generated eight false-positive candidate lesions at 7T versus 24 at 3T. Cross-field prediction concordance was 71% (5/7 locations) in MRI-suspected FCD, but only 26% (8/31) combined MRI-negative and other-lesion subgroups. Thus, a 3T-trained model can identify FCD on 7T MRI without retraining, but 7T MRI did not improve diagnostic yield. Domain adaptation and improved discrimination between FCD and non-FCD findings are needed before clinical deployment at 7T.